Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print.
BackgroundPsoriasis is a chronic autoimmune skin disease, and the imiquimod (IMQ)-induced mouse model is widely used to assess potential therapeutic interventions. Pirfenidone, known for its anti-fibrotic and anti-inflammatory properties, may offer new …